Chronic granulomatous disease: genes and variants
Explore variant evidence for Chronic granulomatous disease across 6 analyzed proteins (NCF2, NCF4, CYBB, NCF1, IFNGR1 and 1 more). Linked ClinVar records include 4 pathogenic or likely pathogenic variants, 4 variants of uncertain significance and 0 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Chronic granulomatous disease
NCF2: Neutrophil cytosol factor 2
It helps activate the phagocyte NADPH oxidase by assembling with membrane and cytosolic partners during the respiratory burst. Biallelic loss-of-function variants cause chronic granulomatous disease and impaired killing of catalase-positive bacteria and fungi.
3 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in NCF2 have source records linked to Chronic granulomatous disease. Association strength is not clinical gene validity.
NCF4: Neutrophil cytosol factor 4
It helps organize and regulate phagocyte NADPH oxidase complexes and contributes to reactive-oxygen-species generation in innate immune cells. Biallelic pathogenic variants can cause a milder chronic-granulomatous-disease-like immunodeficiency with recurrent infection and inflammation.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in NCF4 have source records linked to Chronic granulomatous disease. Association strength is not clinical gene validity.
CYBB: NADPH oxidase 2
It generates the catalytic electron flow that allows phagocytes to produce microbicidal reactive oxygen species during the respiratory burst. Loss-of-function variants cause X-linked chronic granulomatous disease with severe susceptibility to bacterial and fungal infection.
0 ClinVar pathogenic / likely pathogenic and 4 uncertain variants in CYBB have source records linked to Chronic granulomatous disease. Association strength is not clinical gene validity.
NCF1: Neutrophil cytosol factor 1
After phagocyte activation, it joins the NADPH oxidase complex to generate microbicidal reactive oxygen species. Biallelic loss-of-function variants cause chronic granulomatous disease with recurrent bacterial and fungal infections.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in NCF1 have source records linked to Chronic granulomatous disease. Association strength is not clinical gene validity.
IFNGR1: Interferon gamma receptor 1
It binds interferon-gamma and initiates STAT1-dependent antimicrobial and immune-activating programs. Complete or partial loss-of-function variants cause Mendelian susceptibility to mycobacterial disease with severity related to residual signaling.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in IFNGR1 have source records linked to Chronic granulomatous disease. Association strength is not clinical gene validity.
IFNGR2: Interferon gamma receptor 2
It partners with IFNGR1 to transmit interferon-gamma signals into cells through JAK-STAT pathways. Biallelic loss-of-function variants impair macrophage activation and can cause severe susceptibility to poorly pathogenic mycobacteria and related intracellular organisms.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in IFNGR2 have source records linked to Chronic granulomatous disease. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Chronic granulomatous disease
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| NCF4 R105Q | 105 | PX | Pathogenic / likely pathogenic (★★) |
| NCF2 A202V | 202 | Pathogenic / likely pathogenic (★★) | |
| NCF2 Y394D | 394 | PB1 | Pathogenic / likely pathogenic (★★) |
| NCF2 A128V | 128 | TPR 3 | Pathogenic / likely pathogenic (★) |
Same protein, different disease
- Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive also has ClinVar records linked to NCF2 variants; they fall mostly in different places as the Chronic granulomatous disease variants (6 pathogenic / likely pathogenic).
Diseases related to Chronic granulomatous disease
- Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, also linked to NCF1, NCF2 and NCF4
- Granulomatous disease, chronic, X-linked, also linked to CYBB
- X-linked Mendelian susceptibility to mycobacterial diseases due to CYBB deficiency, also linked to CYBB
- Systemic lupus erythematosus, also linked to NCF2
- Disseminated atypical mycobacterial infection, also linked to IFNGR1
Frequently asked questions
Which genes have records linked to Chronic granulomatous disease?
This view contains 6 analyzed proteins: NCF2, NCF4, CYBB, NCF1, IFNGR1 and 1 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 4 pathogenic or likely pathogenic variants, 4 variants of uncertain significance and 0 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 399 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center